15 results on '"Kasi, P.M."'
Search Results
2. 90P Feasibility of using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma
3. 361P Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER
4. LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC
5. 1421P EGFR inhibition in EGFR-amplified esophagogastric cancer (EGC): Retrospective global experience
6. 472P Characterizing the anal microbiome in proximal versus distal colorectal cancer
7. 1415P Performance of a tumor-informed circulating tumor DNA assay from over 250 patients with over 600 plasma time points in esophageal and gastric cancer
8. 551O Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER
9. Epilepsy: Public knowledge and attitude in a slum area of Karachi, Pakistan
10. 520TiP A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer
11. 319MO Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer
12. Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102
13. Liquid biopsy concordance based on clonality and timing of testing in patients with metastatic colorectal cancer
14. 622P - Liquid biopsy concordance based on clonality and timing of testing in patients with metastatic colorectal cancer
15. 4MO Is it time for a new staging system for colon adenocarcinoma (CA)?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.